Batoclimab as induction and maintenance therapy in patients with myasthenia gravis: rationale and study design of a phase 3 clinical trial

Overview of attention for article published in BMJ Neurology Open, January 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#39 of 173)
High Attention Score compared to outputs of the same age (84th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

news: 1 news outlet

twitter: 2 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 8 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 15,926 followers.

RT @JNNP_BMJ: New protocol: Batoclimab as induction and maintenance therapy in patients with myasthenia gravis: rationale and study design…

14 Jan 2024

Reply Repost Favourite

New protocol: Batoclimab as induction and maintenance therapy in patients with myasthenia gravis: rationale and study design of a phase 3 clinical trial https://t.co/XZIldKOeaR https://t.co/8F9MIIUKtt

13 Jan 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.